MRNA Moderna, Inc.

Nasdaq modernatx.com


$ 26.75 $ -0.09 (-0.34 %)    

Monday, 13-Oct-2025 19:59:40 EDT
QQQ $ 601.81 $ 12.51 (2.12 %)
DIA $ 460.92 $ 5.81 (1.28 %)
SPY $ 662.71 $ 10.02 (1.53 %)
TLT $ 90.54 $ -0.05 (-0.06 %)
GLD $ 379.71 $ 8.97 (2.43 %)
$ 26.74
$ 27.24
$ 26.72 x 5
$ 26.90 x 4
$ 26.60 - $ 28.06
$ 23.15 - $ 58.96
9,187,262
na
10.4B
$ 1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-21-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-23-2024 12-31-2023 10-K
8 11-03-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-24-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-03-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-26-2021 12-31-2020 10-K
20 10-30-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 moderna-reports-promising-response-rates-for-skin-cancer-combo-therapy-in-resistant-patients

Moderna's Phase 1/2 study shows mRNA-4359 plus pembrolizumab yields 24% response rate and 60% disease control in resistant ...

 reported-sunday-moderna-presents-early-phase-12-data-showing-24-response-rate-for-mrna-4359-in-checkpoint-inhibitor-resistant-melanoma

mRNA-4359 has advanced into the Phase 2 portion of the ongoing Phase 1/2 trial

 morgan-stanley-maintains-equal-weight-on-moderna-raises-price-target-to-32

Morgan Stanley analyst Matthew Harrison maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and raises the price target from...

 trump-pfizer-deal-pushes-health-care-stocks-to-best-rally-in-5-years

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tari...

 moderna-stock-is-rallying-wednesday-whats-driving-the-action

Moderna stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector.

 robert-f-kennedy-jr-faces-impeachment-push-from-haley-stevens-over-health-care-chaos-and-rising-costs-enough-is-enough

Rep. Haley Stevens (D-Mich.) announced that she will introduce articles of impeachment against Health and Human Services Secret...

 moderna-stands-by-uk-as-pharma-giants-criticize-pricing-uk-secures-first-onshore-mrna-vaccine-production-centre

Moderna, Inc.‘s (NASDAQ: MRNA) UK chief Darius Hughes defended Britain's drug pricing policies after the country was brande...

 reported-earlier-moderna-uk-facility-to-produce-100m-mrna-doses-annually-with-250m-surge-capacity-under-ten-year-partnership-strengthening-health-resilience

The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply...

Core News & Articles

https://www.nature.com/articles/d41586-025-03093-6

 modernas-covid-19-vaccine-update-boosts-antibodies-16-fold-data-shows

Moderna's 2025-2026 mNEXSPIKE showed strong immune response and safety in Phase 4 trials, reinforcing FDA approval for the ...

 moderna-preliminary-analysis-show-2025-2026-formula-of-mnexspike-generated-greater-than-a-16-fold-increase-in-lp81-neutralizing-antibodies-across-age-groups

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing...

 trump-advises-parents-to-split-vaccines-delay-hepatitis-b-shots-until-age-12-this-is-based-on-what-i-feel

President Donald Trump on Monday offered advice on childhood vaccination schedules, encouraging parents to split up certain imm...

 stocks-extend-records-gold-soars-to-3740-whats-moving-markets-monday

Wall Street is on track for its third straight day of gains, with major large-cap indices extending records as investors remain...

Core News & Articles

- Reuters 

Core News & Articles

- Reuters

 moderna-ships-first-mrna-vaccines-fully-manufactured-in-canada-advancing-domestic-vaccine-production-capacity-and-strengthening-national-health-security

Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinces and territorie...

 elizabeth-warren-says-measles-can-hit-record-highs-slams-rfk-jrs-cdc-panel-for-delaying-vaccine-how-does-that-keep-our-kids-safe

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory pa...

 whats-going-on-with-moderna-stock-wednesday

Moderna shares are trading marginally lower Wednesday morning. Tuesday's rally was driven by the release of positive prelim...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION